Literature DB >> 20483485

Is the EFNB2 locus associated with schizophrenia? Single nucleotide polymorphisms and haplotypes analysis.

Rui Zhang1, Nan-Nan Zhong, Xiao-Gang Liu, Han Yan, Chuan Qiu, Yan Han, Wei Wang, Wei-Kun Hou, Yue Liu, Cheng-Ge Gao, Ting-Wei Guo, She-Min Lu, Hong-Wen Deng, Jie Ma.   

Abstract

Recently, evidence of linkage of schizophrenia to chromosome 13q22-q34 has been demonstrated in multiple studies. Based on structure and function, EFNB2 may be considered as a compelling candidate gene for schizophrenia on chromosome 13q33. We genotyped three single-nucleotide polymorphisms (SNPs: rs9520087, rs11069646, and rs8000078) in this region in 846 Han Chinese subjects (477 cases and 369 controls). Significant association between an allele of marker rs9520087 and schizophrenia was found. Furthermore, since no LD was observed in the three SNPs linkage disequilibrium estimation, all three SNPs were used in multiple SNPs haplotype analysis, and a strongly significant difference was found for the common haplotype TTC. Overall our findings indicate that EFNB2 gene may be a candidate susceptibility gene for schizophrenia in the Han Chinese population, and also provide further support for the potential importance of the NMDA receptor pathway in the etiology of schizophrenia.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20483485     DOI: 10.1016/j.psychres.2010.04.037

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  11 in total

1.  Ephrin/Ephrin receptor expression in ammonia-treated rat astrocytes and in human cerebral cortex in hepatic encephalopathy.

Authors:  Karmela Sobczyk; Markus S Jördens; Ayse Karababa; Boris Görg; Dieter Häussinger
Journal:  Neurochem Res       Date:  2014-07-27       Impact factor: 3.996

Review 2.  Ephrin regulation of synapse formation, function and plasticity.

Authors:  Martin Hruska; Matthew B Dalva
Journal:  Mol Cell Neurosci       Date:  2012-03-15       Impact factor: 4.314

Review 3.  Eph receptors and ephrins: therapeutic opportunities.

Authors:  Antonio Barquilla; Elena B Pasquale
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-03       Impact factor: 13.820

Review 4.  Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia.

Authors:  Meng Xia; Sofya Abazyan; Yan Jouroukhin; Mikhail Pletnikov
Journal:  Schizophr Res       Date:  2014-11-20       Impact factor: 4.939

Review 5.  Psychiatric behaviors associated with cytoskeletal defects in radial neuronal migration.

Authors:  Toshifumi Fukuda; Shigeru Yanagi
Journal:  Cell Mol Life Sci       Date:  2017-05-17       Impact factor: 9.261

6.  Genetic evidence for the association between the early growth response 3 (EGR3) gene and schizophrenia.

Authors:  Rui Zhang; Shemin Lu; Liesu Meng; Zixin Min; Juan Tian; Robert K Valenzuela; Tingwei Guo; Lifang Tian; Wenxiang Zhao; Jie Ma
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

7.  Isochromosome 13 in a patient with childhood-onset schizophrenia, ADHD, and motor tic disorder.

Authors:  Sharon L Graw; Karen Swisshelm; Kirsten Floyd; Billie J Carstens; Marianne Z Wamboldt; Randall G Ross; Sherry Leonard
Journal:  Mol Cytogenet       Date:  2012-01-03       Impact factor: 2.009

8.  Attention: Schizophrenia Risk Gene Product miR-137 Now Targeting EFNB2.

Authors:  Paul A Tooney
Journal:  EBioMedicine       Date:  2016-10-05       Impact factor: 8.143

Review 9.  Regulation of membrane NMDA receptors by dynamics and protein interactions.

Authors:  Mar Petit-Pedrol; Laurent Groc
Journal:  J Cell Biol       Date:  2021-01-04       Impact factor: 10.539

10.  MicroRNA-137 Inhibits EFNB2 Expression Affected by a Genetic Variant and Is Expressed Aberrantly in Peripheral Blood of Schizophrenia Patients.

Authors:  Shanshan Wu; Rui Zhang; Fayi Nie; Xiaoli Wang; Congshan Jiang; Meng Liu; Robert K Valenzuela; Wanqing Liu; Yongyong Shi; Jie Ma
Journal:  EBioMedicine       Date:  2016-09-15       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.